Chong Kun Dang exclusively sells female sexual dysfunction treatment for the first time in Korea
Chong Kun Dang(CEO Young-joo Kim) established an exclusive sales agreement of a female sexual dysfunction treatment with S1 Biopharma, a U.S. company, at the Chong Kun Dang headquarters at Chungjeongno, Seoul, for the first time in Korea on the 4th.
The drug is currently under a phase 2 clinical...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
